OHSU Research and Innovation is compiling a running list of COVID-19 research opportunities. We publish the list every Thursday. A pdf of the list is also available.
Featured Opportunities
Doris Duke Charitable Foundation, the Burroughs Wellcome Fund, Rita Allen Foundation and Walder Foundation COVID-19 Fund to Retain Clinical Scientists
What: Grant opportunity for U.S. medical schools that are evolving to strengthen policies, practices and processes to support the research productivity and retention of early-career faculty with family caregiving responsibilities
Who should apply: Researchers conducting an original and rigorous clinical research project that has the potential to address a health issue that poses a significant clinical burden who are early-career faculty, defined as a having a full-time, post-training instructor or assistant professor faculty appointment and demonstrate a compelling, time-sensitive need for the supplement to regain research momentum because of increased family caregiving responsibilities caused by COVID-19
Award: Up to $500,000/two years
Deadline: LOI due: June 22, 2021, noon PT; Application due: July 20, 2021, noon PT
NSF Predictive Intelligence for Pandemic Prevention Phase I: Development Grants (PIPP Phase I)
What: Supports research on articulation of an NSF grand challenge centered around a critical and broad question in pandemic predictive intelligence, proposals of novel conceptual research and technology developments that aim to advance state-of-the-art forecasting, real-time monitoring, mitigation and prevention of the spread of pathogens, and multidisciplinary team formation
Who should apply: PIs and co-PIs with balanced participation from computer and information science, biology, engineering and social, behavioral and economic sciences
Award: Up to $25 million in total funding with 25 to 30 estimated awards/one and a half years
Deadline: Oct. 1, 2021, 5 p.m. PT
Internal Opportunities
OHSU Knight Cancer Institute Faculty COVID-relief Awards
What: Supplemental funding for innovative junior and mid-level OHSU faculty research projects in the spirit of COVID-relief
Who should apply: Assistant or associate professors who are sufficiently focused on cancer-related research (research assistant/associate professors and full professors are excluded from this opportunity)
Award: Up to $75,000/one year
Deadline: June 28, 2021
Apply through the CAP
OHSU Knight Cancer Institute PhD Scholar COVID-relief Awards
What: Supplemental funding for innovative PhD Scholar research projects in the spirit of COVID-relief
Who should apply: PhD Scholars who are sufficiently focused on cancer-related research and have support from a faculty advisor
Award: Up to $50,000/one year
Deadline: June 28, 2021
Apply through the CAP
NIH
NIH Guidance
AHRQ Guide Notice on Exception to the Use of the Single IRB Review Requirements During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency
NHLBI Notice of Information: NHLBI Extensions for Career Development Award (K01, K08, K23, K25) Recipients Whose Career Trajectories Have Been Significantly Impacted by COVID-19
What: Additional guidance for currently-funded NHLBI K01, K08, K23, and K25 recipients impacted by COVID-19 seeking funded extensions
NIAAA Notice of Clarification of Research Priorities for RFA-AA-21-002 “SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed)”, RFA-AA-21-003 “SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed)” and RFA-AA-21-004 “SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed)”
NIAID Funded Extensions for Career Award Recipients Whose Career Trajectories Have Been Significantly Impacted by COVID-19
What: Opportunity for select K award recipients in the last year of their award, or in their first no-cost extension, to apply for a funded extension to support their career development to facilitate successful transition to research independence
NIAID Funded Extensions for Fellowship Award Recipients Whose Career Trajectories Have Been Significantly Impacted by COVID-19
What: Opportunity for select F award recipients in the last year of their award to apply for a funded extension to support their career development to facilitate successful transition to research independence
NIAID Notice to Extend Eligibility for Submission of NIAID K99 /R00 Pathway to Independence Award Applications (and Physician-Scientist K99/R00) due to COVID–related Disruptions
What: NIAID will extend eligibility for submission of K99/R00 applications due to COVID–related disruptions
NINDS Temporary Extension of Eligibility for the NINDS F32 Award Due the COVID-19 Pandemic
Office of The Director Continuation of Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic
Office of The Director Exceptions to Use of a Single IRB During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency
What: NIH-funded research studies subject to the 2018 requirements for the Federal Policy for the Protection of Human Subjects and its cooperative research provision and that are ongoing or initially reviewed by the Institutional Review Board during the COVID-19 public health emergency may request an exception to the use of a single IRB
Office of The Director Extended Guidance for Applicants Preparing Applications During the COVID-19 Pandemic
What: Notice to extend the guidance that NIH grant applications should NOT include contingency plans that would outline steps needed to recover from temporary, emergency situations, or institutional return-to-the-workplace plans, resulting from the COVID-19 pandemic
Office of The Director Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: January 2022 Council
See also: Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic
And: Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: August/October 2021 Councils
Office of The Director Guidance for Applicants Preparing Applications for the Fall 2020 Due Dates During the COVID-19 Pandemic
What: Guidance for investigators and institutions preparing NIH grant applications for the May 2021 Council round, beginning with applications submitted for the September 25, 2020 due date
Office of The Director Reminder – Requesting Extensions for Early Career Scientists Whose Career Trajectories Have Been Significantly Impacted by COVID-19
What: Reminder that NIH is providing an opportunity for recipients of NIH Fellowship and NIH Career Development awards who have been impacted by COVID-19 to request no-cost and funded extensions
Office of the Director Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic
What: Due to disruptions caused by the COVID-19 pandemic, NIH will be providing up to a two-receipt cycle extension (roughly eight additional months) of eligibility for prospective applicants meeting the requirements for submission of a K99/R00 application from the time period covered by the June/July 2020 due dates through the February/March 2021 due dates. Under normal circumstances, individuals must have no more than four years of postdoctoral research experience to be eligible to apply for a K99/R00 award
NIH Point-of-Care Technology Research Network
NIBIB and NIH POCTRN Fast-Track Program for COVID-19 Test Development and Distribution
What: Funding to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities with the help of the Rapid Acceleration of Diagnostics (RADx) technology development program
Who should apply: Anyone with a research interest in diagnostics for SARS-CoV-2
Award: Projects are broken into three phases, and funding amount is dependent upon phase; see FOA for more details
Deadline: Open on a rolling basis
Parent Announcements
PA-18-935 Multiple NIH Organizations Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement – Clinical Trial Optional)
What: FOA to submit applications for urgent competitive revisions; intended to provide funds for NIH grantees applying to expand the scope of their active grant
Who should apply: Anyone with an active grant from one of the participating organizations who can accomplish their research within the competitive segment of the active award
Award: No minimum or maximum/within duration of the parent award
Deadline: Open dates vary by awarding IC
PA-20-135 Multiple NIH Organizations Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional)
What: : FOA to submit applications for emergency competitive revisions; offers NIH grantees additional funds for research responsive to the 2019-nCoV outbreak that falls within the scope of an ongoing grant
Who should apply: Anyone with an active grant from one of the participating organizations, such as the NIAID, who can accomplish their research within the competitive segment of the active award
Award: No minimum or maximum/within duration of the parent award
Deadline: Open dates vary by awarding IC
Applies to PA-18-935
NCI Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be Redirected to COVID-19-related Research During the Crisis
What: The NCI is considering requests from its funded grantees and cooperative agreement awardees to engage in limited COVID-19 related research using part of their existing NCI-funded resources under certain conditions
Who should apply: Current NCI-funded grantees
Award: Funding amount must be within the existing award budget/for the duration of the pandemic
Deadline: For the duration of the COVID-19 crisis
NIGMS NOSI: Availability of Urgent Award for Competitive Revisions to IDeA-CTR Awards to Address the Continued Need for Documenting COVID-19-Related Patient Outcomes
What: Notice of supplements to serve the continued need for documenting COVID-19-related patient outcomes among medically underserved populations
Who should apply: Grantees with an active NIGMS IDeA-CTR U54 award
Award: Up to $2 million/one year
Deadline: June 18, 2021, 5 p.m. PT
Multiple NIH Organizations NOSI regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project
What: Aims to highlight the urgent need for research on SARS-CoV-2 and COVID-19 in individuals with Down syndrome in conjunction with the INCLUDE Project
Who should apply: Currently funded grantees under one of the sponsoring organizations
Award: Up to $1 million/one year
Deadline: July 12, 2021, 5 p.m. PDT
NIGMS NOSI: Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2
What: Supports incorporation of data related to SARS-CoV-2 into ongoing research efforts to develop predictive computational models for the spread of SARS-CoV-2 and other related infectious agents
Who should apply: Active NIH grantees
Award: Not limited/no longer than the duration of the parent award
Deadline: Rolling through Dec. 15, 2021
NIDA NOSI Announcing the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus
What: Notice to highlight the urgent need for continued research on the impacts of SARS-CoV-2; NIDA is especially interested in research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders
Who should apply: Active NIDA grantees
Award: Up to $200,000/up to two years
Deadline: Rolling through March 31, 2022
Applies to PA-20-135
NIAID NOSI regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
What: Highlights very specific and limited needs for Competitive Revision applications to active NIAID grants in order to further build the infrastructure that NIAID needs to support the SARS-CoV-2 and COVID-19 research response
Who should apply: PIs on active NIAID grants
Award: No more than the annual amount of the current parent award/up to two years
Deadline: Rolling through July 2, 2021
NCATS NOSI regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus
What: Supports research on the use of microphysiological systems or tissue chips in collecting and examining data on the risks and outcomes for COVID-19 infection
Who should apply: Anyone with funding through the NIH Microphysiological Systems Program, microphysiological systems programs from across NIH and SBIR/STTR-supported investigators provided the award involves tissue chips
Award: No more the current amount of the parent award/up to two years
Deadline: Open through Jan. 25, 2022
NCATS NOSI: Availability of Emergency Competitive Revisions for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs
What: Supports high-priority clinical studies and trials to test therapeutics for COVID-19
Who should apply: Current Clinical and Translational Science Award (CTSA) UL1 and U24 award recipients
Award: Not limited/no longer than the duration of the parent award
Deadline: Open through Aug. 16, 2024
FOAs
NCATS Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required)
What: Supports research to repurpose existing therapeutic agents to treat COVID-19 sequelae and associated complications that result from SARS-CoV-2 infections
Who should apply: Anyone with a research interest in repurposing therapeutic agents
Award: Up to $9 million/up to three years
Deadline: Rolling starting Aug. 6, 2020
FDA Pediatric and Perinatal COVID-19 Registry (U18) Clinical Trials Optional
What: Supports the development of a compendium-type resource incorporating pediatric and perinatal COVID-19 registries, natural history and other data to support the linkage of mother-infant pair data in COVID-19 positive mothers and to identify the short and longer-term outcomes in neonates and infants who are perinatally exposed to and/or test positive for SARS CoV-2
Who should apply: Anyone with a research interest in mother-infant health relationships and COVID-19
Award: Up to $2 million/up to two years
Deadline: July 6, 2021, 8:59 p.m. PT
Multiple NIH Organizations Emergency Awards: Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations – RADx-UP Phase II (U01 Clinical Trial Optional)
What: Supports research to expand the scope and reach of RADxSM-UP testing interventions to reduce COVID-19 disparities among underserved and vulnerable populations and address scientific questions on interventions to increase access and uptake of COVID-19 testing given the increasing availability of SARS-CoV-2 vaccines
Who should apply: Anyone with a research interest in COVID-19 testing disparities
Award: Up to $1.5 million/up to two years
Deadline: July 7, 2021, 5 p.m. PT
Multiple NIH Organizations Emergency Award: RADx-UP – Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trials Optional)
What: Supports research to expand research to understand and address the social, ethical and behavioral implications of COVID-19 testing interventions among underserved and vulnerable populations
Who should apply: Anyone with a research interest in COVID-19 and social, ethical and behavioral implications
Award: Up to $800,000/up to two years
Deadline: July 7, 2021, 5 p.m. PT
Multiple NIH Organizations Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed)
What: Supports research on the impact of SARS-CoV-2 and associated mitigation efforts on individual, family and community behavior and how subsequent economic disruption affects health outcomes with close attention to underserved and vulnerable populations
Who should apply: Anyone with a research interest in social, behavioral and economic research related to COVID-19
Award: Up to $2.5 million/up to five years
Deadline: Nov. 8 2021, 5 p.m. PT
Other Notices of Special Interest
NCATS NOSI: Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need
What: Solicits applications for Administrative Supplements to UL1, U01, and R21 awards (through PA-18-591), Collaborative Innovation Awards to U01 and R21 awards (through PAR-19-099 and PAR-19-100, respectively), and Competitive Revisions for UL1 awards for each of the non-administrative supplement awards (through PAR-19-337)
Who should apply: Anyone with an active grant with an activity code listed above from the NCATS
Award: Dependent upon FOA you apply through
Deadline: Dependent upon FOA you apply through
NCATS NOSI: Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)
What: Supports projects that repurpose existing drugs or biologics (existing therapeutics) that have already begun or completed a Phase I clinical trial to study SARS-CoV-2 and COVID-19
Who should apply: Specific eligibility not listed
Award: Dependent upon FOA you apply through
Deadline: Dependent upon FOA you apply through
NIDA NOSI: Effects of smoking and vaping on the risk and outcome of COVID-19 infection
What: Supports research on the effects of smoking or vaping tobacco or marijuana on the risk of acquiring COVID-19 and the clinical course of the infection
Who should apply: Anyone with a research interest in COVID-19 and smoking and vaping
Award: Dependent upon FOA you apply through
Deadline: Open through Sept. 7, 2024
NIAID NOSI on Pan-Coronavirus Vaccine Development Program Projects
What: Supports research that incorporates understanding of CoV virology and immunology, immunogen design and vaccine and adjuvant platforms and technologies to discover, design and develop pan-coronavirus vaccine candidates that provide broad protective immunity to multiple CoV strains
Who should apply: Anyone with a research interest in pan-coronavirus vaccines
Award: Not limited/up to five years
Deadline: June 11, 2021
NIDA and NIMH Notice of Special Interest (NOSI): Research on Strategies to Enhance Mental Health Interventions and Services within Employment and Job Training Settings
What: Supports research focused on detection and intervention to prevent or treat mental health concerns, symptoms or disorders including drug-related conditions among unemployed and underemployed people participating in employment programs and job training settings
Who should apply: Anyone with a research interest in mental health and underemployment/unemployment
Award: Dependent upon FOA you apply through
Deadline: Open from June 15, 2021 through Sept. 8, 2023
NICHD and ORWH NOSI to Encourage Administrative Supplement Applications to Investigate COVID-19 Vaccination and Menstruation (Admin Supp – Clinical Trial Optional)
What: Supports targeted supplement applications to examine the impact of SARS-CoV-2 vaccines on menstruation
Who should apply: Grantees with active NICHD parent awards focused on clinical research; non-NICHD parent awards will be considered if deemed compelling
Award: Up to $300,000/one year
Deadline: June 17, 2021, 5 p.m. PT
NIAMS Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases
What: Encourages basic, translational, pre-clinical and clinical observational research focused on COVID-19 infection and its intersection with rheumatic, musculoskeletal, and skin diseases and conditions
Who should apply: Anyone with a research interest in COVID-19 and diseases within the NIAMS mission
Award: Dependent upon FOA you apply through
Deadline: Open through Nov. 18, 2021
Multiple NIH Organizations NOSI: Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities
What: Supports research strategies and interventions to address vaccine hesitancy, uptake and implementation among populations who experience health disparities in the US
Who should apply: Anyone with a research interest in vaccine hesitancy
Award: Not limited/up to five years
Deadline: Open through Jan. 8, 2022
NCATS NOSI regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus
What: Supports research on the use of microphysiological systems or tissue chips in collecting and examining data on the risks and outcomes for COVID-19 infection
Who should apply: Anyone with funding through the NIH Microphysiological Systems Program, microphysiological systems programs from across NIH and SBIR/STTR-supported investigators provided the award involves tissue chips
Award: No more than 25 percent of the total costs of the amount of the parent award/up to one year
Deadline: Open through Jan. 25, 2022
NICHD and NIMH NOSI: COVID-19 Related School Disruptions Impact on Mental Health, Cognitive, Social, and Emotional Development of Children
What: Supports research to understand the mental health impact of the COVID-19 pandemic on school-aged children, specifically ages 3 to 12
Who should apply: Anyone with a research interest in the pandemic’s effect on children’s mental health
Award: Not limited/up to five years
Deadline: Open through Sept. 8, 2022
NIDCD NOSI: NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders
What: Supports research on COVID-19 in relation to NIDCD’s scientific programs of hearing, balance, taste, smell, voice, speech and language
Who should apply: Specific eligibility not listed
Award: Dependent upon FOA you apply through
Deadline: Open through Sept. 8, 2022
NIA NOSI: Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 in Aging and Age-Related Neurodegeneration
What: Supports basic and clinical mechanistic research on neurological and neurocognitive sequelae originating from SARS-CoV-2 infection and COVID-19 in aging and age-related neurodegeneration
Who should apply: Anyone with a research interest in COVID-19 and aging and age-related neurodegeneration
Award: Dependent upon FOA you apply through
Deadline: Open through May 7, 2023
Multiple NIH Organizations NOSI: Simulation Modeling and Systems Science to Address Health Disparities
What: Supports investigative and collaborative research focused on developing and evaluating simulation modeling and systems science to understand and address minority health and health disparities, including those related to COVID-19
Who should apply: Anyone with a research interest in modeling systems and health disparities
Award: Not limited/up to five years
Deadline: Open through May 8, 2023
NIA NOSI: Aging-Relevant Behavioral and Social Research on Coronavirus Disease 2019 (COVID-19)
What: Supports research on the longer-term effects of COVID-19 on the health and well-being of those infected, those caring for the sick and others whose lives were disrupted by the pandemic and its associated mitigation and prevention strategies
Who should apply: Anyone with a research interest in COVID-19 and behavioral, social and aging research
Award: Dependent upon FOA you apply through
Deadline: Open through May 8, 2023
NICHD Notice of Special Interest (NOSI) – Research on Rehabilitation Needs Associated with the COVID-19 Pandemic
What: Encourages research to address the rehabilitation needs of survivors of COVID-19, understand the impact of disruptions to rehabilitation services caused by the COVID-19 pandemic and associated mitigation actions and understand the social, behavioral, economic, and health impact of the COVID-19 pandemic and the associated mitigation actions on people with physical disabilities
Who should apply: Anyone with a research interest in rehabilitation and COVID-19
Award: Award and duration not specified
Deadline: Open through May 8, 2023
NIDCR NOSI: NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19)
What: Supports research studies focused on the physiological involvement of oral cavity and oral manifestations related to SARS-CoV-2 and/or COVID-19
Who should apply: Anyone with a research interest in COVID-19 and the oral cavity
Award: Dependent upon FOA you apply through
Deadline: Open through May 8, 2023
NIMH Notice of Special Interest: Administrative Supplements for COVID-19 Impacted NIMH Research
What: Supports administrative supplements to cover unanticipated costs caused by the COVID-19 pandemic or related mitigation efforts that could not be covered by rebudgeting existing funds
Who should apply: Investigators and institutions with active NIMH awards that have been significantly impacted by COVID-19
Award: No more than the parent award/no longer than the parent award
Deadline: Open through June 1, 2023
NICHD and ORWH Notice of Special Interest: Emerging Viral Infections and their Impact on the Male and Female Reproductive Tract
What: Supports applications proposing cutting-edge research on emerging viral infections including COVID-19 and Zika that are thought to primarily impact non-reproductive sites, at least at initial presentation, but may also affect the male and/or female reproductive tract
Who should apply: Anyone with a research interest in viral infections and reproductive tracts
Award: Dependent upon the parent award you apply through
Deadline: Open through July 16, 2023
NICHD and SGMRO NOSI: Research on the Impact of the Covid 19 Pandemic and Risks for Abuse and Injury Among Vulnerable Children and Youth
What: Call for more data and research resources to identify, substantiate and improve care and ultimately outcomes for vulnerable children and youth during and following the current crisis
Who should apply: Anyone with a research interest in COVID-19 and child abuse
Award: Dependent upon FOA you apply through
Deadline: Open through May 31, 2024
NCATS NOSI: Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs
What: Supplements for projects that address the COVID-19 Public Health Emergency through Clinical and Translational Science Award Program recipients
Who should apply: Active Clinical and Translational Science Award UL1 component award recipients
Award: No more than the parent award/up to two years
Deadline: Open through Aug. 16, 2024
NIDA NOSI: Effects of smoking and vaping on the risk and outcome of COVID-19 infection
What: Supports research on the effects of smoking or vaping tobacco or marijuana on the risk of acquiring COVID-19 and the clinical course of the infection
Who should apply: Anyone with a research interest in COVID-19 and smoking and vaping
Award: Dependent upon FOA you apply through
Deadline: Open through Sept. 7, 2024
NIDA NOSI: Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders
What: Supports research focused on studying the long-term neurocognitive consequences of the COVID-19/HIV/SUDs syndemic
Who should apply: Anyone with a research interest in COVID-19 and HIV-positive individuals with substance use disorders
Award: Dependent upon FOA you apply through
Deadline: Open from through Sept. 7, 2024
NIDA NOSI: Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19
What: Supports research focused on individuals with HIV who smoke or vape marijuana, tobacco, cocaine and/or methamphetamine to determine the long-term effects of their use among individuals with HIV and COVID-19
Who should apply: Anyone with a research interest in COVID-19 and HIV-positive individuals with substance use disorders
Award: Dependent upon FOA you apply through
Deadline: Open through Sept. 7, 2024
Other Federal Organizations
BARDA
BARDA DRIVe EZ-BAA
What: The current EZ-BAA solicitation (BAA-20-100-SOL-0002) includes an Area of Interest on developing technologies for early detection of COVID-19 through monitoring health status
Who should apply: Anyone with a research interest in early detection of COVID-19
Award: Up to $749,000/not specified
Deadline: Rolling through Feb. 3, 2023
NSF
NSF Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19)
What: Calls for proposals to conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19; apply through existing funding opportunities and the Rapid Response Research funding mechanism
Who should apply: No specific eligibility guidelines; direct proposals either to a program officer managing an NSF program with which the research would be aligned or to rapid-covid19@nsf.gov
Award: Up to $200,000/up to one year for RAPID proposals
Deadline: Open
NSF Rapid Response Research (RAPID) Funding Mechanism
What: Proposal used when there is a severe urgency with regard to availability of or access to data, facilities or specialized equipment, including quick-response research on natural or anthropogenic disasters and similar unanticipated events
Who should apply: No specific eligibility guidelines; direct proposals either to a program officer managing an NSF program with which the research would be aligned or to rapid-covid19@nsf.gov
Award: Up to $200,000/up to one year
Deadline: Open
New this week!
NSF Predictive Intelligence for Pandemic Prevention Phase I: Development Grants (PIPP Phase I)
What: Supports research on articulation of an NSF grand challenge centered around a critical and broad question in pandemic predictive intelligence, proposals of novel conceptual research and technology developments that aim to advance state-of-the-art forecasting, real-time monitoring, mitigation and prevention of the spread of pathogens, and multidisciplinary team formation
Who should apply: PIs and co-PIs with balanced participation from computer and information science, biology, engineering and social, behavioral and economic sciences
Award: Up to $25 million in total funding with 25 to 30 estimated awards/one and a half years
Deadline: Oct. 1, 2021, 5 p.m. PT
Private Organizations
COVID-19 Early Treatment Fund Outpatient Trials for Repurposed Drugs
What: Funds outpatient clinical trials to repurpose existing drugs for effective COVID-19 treatment with the goal of rapidly testing and implementing the use of drugs that have already gone through extensive safety testing and are currently approved and marketed for other indications
Who should apply: Anyone with a research interest in repurposing drugs for COVID-19 treatment
Award: Not specified
Deadline: Not specified
ImpactAssets Stop the Spread COVID Response Program
What: Call to companies and organizations to spur development of PPE for both medical and non-medical use, novel testing solutions, widely-accessible therapeutics and digital health solutions to address the needs of underserved communities and vulnerable populations
Who should apply: Anyone with a research interest in PPE
Award: Not limited
Deadline: Not specified
Oak Ridge National Laboratory Call for Rapid Access Proposals for COVID-19 Research
What: Supports research into the COVID-19 virus and the search for effective diagnostics and therapies through the use of neutron macromolecular crystallography, small angle scattering, reflectometry, spectroscopy and imaging beamlines
Who should apply: Researchers who would like to use these resources should submit a short rapid access proposal, outlining experiment aims and scope
Award: Access to the beamlines at the Spallation Neutron Source (SNS) and High Flux Isotope Reactor (HFIR) at Oak Ridge National Laboratory
Deadline: Rolling
Robert Wood Johnson Foundation Pioneering Ideas: Exploring the Future to Build a Culture of Health
What: Supports proposals to address any of these four areas of focus: Future of Evidence, Future of Social Interaction, Future of Food and Future of Work; not directly aimed at COVID-19 but proposals can be related to the pandemic
Who should apply: Anyone who wants to research COVID-19 and health equity
Award: No minimum or maximum, average amount $315,031/generally between one to three years
Deadline: Rolling
This organization is on the President’s List; submit a notice of intent form before applying
Doris Duke Charitable Foundation, the Burroughs Wellcome Fund, Rita Allen Foundation and Walder Foundation COVID-19 Fund to Retain Clinical Scientists
What: Grant opportunity for U.S. medical schools that are evolving to strengthen policies, practices and processes to support the research productivity and retention of early-career faculty with family caregiving responsibilities
Who should apply: Researchers conducting an original and rigorous clinical research project that has the potential to address a health issue that poses a significant clinical burden who are early-career faculty, defined as a having a full-time, post-training instructor or assistant professor faculty appointment and demonstrate a compelling, time-sensitive need for the supplement to regain research momentum because of increased family caregiving responsibilities caused by COVID-19
Award: Up to $500,000/two years
Deadline: LOI due: June 22, 2021, noon PT; Application due: July 20, 2021, noon PT
Robert Wood Johnson Foundation Research in Transforming Health and Health Care Systems
What: Supports research studies that evaluate or predict how enrollees are effected by Medicaid policy changes enacted in response to the COVID-19 pandemic
Who should apply: Anyone with a research interest in Medicaid and racial inequity
Award: Up to $350,000/not specified
Deadline: LOI due: June 28, 2021, noon PT; Application due: Nov. 1, 2021, noon PT
This organization is on the President’s List; submit a notice of intent form before applying
